Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.703
Filter
1.
Commun Biol ; 7(1): 779, 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38942984

ABSTRACT

The Mycoplasma Immunoglobulin Binding/Protease (MIB-MIP) system is a candidate 'virulence factor present in multiple pathogenic species of the Mollicutes, including the fast-growing species Mycoplasma feriruminatoris. The MIB-MIP system cleaves the heavy chain of host immunoglobulins, hence affecting antigen-antibody interactions and potentially facilitating immune evasion. In this work, using -omics technologies and 5'RACE, we show that the four copies of the M. feriruminatoris MIB-MIP system have different expression levels and are transcribed as operons controlled by four different promoters. Individual MIB-MIP gene pairs of M. feriruminatoris and other Mollicutes were introduced in an engineered M. feriruminatoris strain devoid of MIB-MIP genes and were tested for their functionality using newly developed oriC-based plasmids. The two proteins are functionally expressed at the surface of M. feriruminatoris, which confirms the possibility to display large membrane-associated proteins in this bacterium. However, functional expression of heterologous MIB-MIP systems introduced in this engineered strain from phylogenetically distant porcine Mollicutes like Mesomycoplasma hyorhinis or Mesomycoplasma hyopneumoniae could not be achieved. Finally, since M. feriruminatoris is a candidate for biomedical applications such as drug delivery, we confirmed its safety in vivo in domestic goats, which are the closest livestock relatives to its native host the Alpine ibex.


Subject(s)
Bacterial Vaccines , Mycoplasma , Bacterial Vaccines/immunology , Bacterial Vaccines/genetics , Mycoplasma/genetics , Mycoplasma/immunology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Immunoglobulins/genetics , Immunoglobulins/metabolism , Immunoglobulins/immunology , Gene Expression Regulation, Bacterial , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/immunology , Mycoplasma Infections/prevention & control , Goats
2.
Avian Dis ; 68(2): 145-155, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38885057

ABSTRACT

Manufacturers of Mycoplasma gallisepticum (MG) modified live vaccines usually recommend a single application at 8 wk of age. This makes 12-16-wk-old layer pullets suitable for challenge studies intended to evaluate these vaccines. Numerous challenge models in different poultry species and ages have been reported. However, there is not an established layer pullet challenge model for this age. The aim of this study is to develop a suitable challenge model in 12-wk-old layer pullets. MG Rlow strain was used as the challenge strain, and its ability to induce clinical signs and lesions in 12-wk-old Hy-Line W-36 layer pullets was evaluated. Three different doses (low, 7.95 × 104 color-changing units [CCU]/bird; medium, 7.95 × 106 CCU/bird; and high, 7.95 × 108 CCU/bird) via three different routes (eye drop, fine spray, and contact infection) were compared and evaluated using different parameters. At 14 days post-challenge, there were no mortalities in any of the groups throughout the study. Layer pullets directly challenged with the high dose via the fine spray route showed the clearest and most consistent results (clinical signs, positive quantitative real-time PCR [qPCR], seroconversion, air sac scoring, and histopathological changes of the tracheal mucosa). Medium and low challenge doses applied via fine spray or eye drop did not show consistent results. Rlow strain was able to spread to the contact infection birds, as confirmed by the positive qPCR results; however, none of the contact-infected birds showed any clinical signs or gross or microscopic lesions. Our results suggest that a high dose (7.95 × 108 CCU/bird) administered through a fine spray route is the model of choice in any future MG vaccine evaluation trials in 12-wk-old layer pullets.


Nota de investigación- Desarrollo y evaluación del modelo de desafío para Mycoplasma gallisepticum en pollitas de postura. Los fabricantes de vacunas vivas modificadas contra Mycoplasma gallisepticum (MG) suelen recomendar una sola aplicación a las ocho semanas de edad. Esto hace que las pollitas de postura de 12 a 16 semanas de edad sean adecuadas para estudios de desafío destinados a evaluar estas vacunas. Se han reportado numerosos modelos de desafío en diferentes especies y edades de aves de corral. Sin embargo, no existe un modelo de desafío establecido para pollitas de postura de esta edad. El objetivo de este estudio fue desarrollar un modelo de desafío adecuado en pollitas ponedoras de 12 semanas de edad. Se utilizó la cepa Rlow de Mycoplasma gallisepticum como cepa de desafío y se evaluó su capacidad para inducir signos clínicos y lesiones en pollitas ponedoras Hy-Line W-36 de 12 semanas de edad. Tres dosis diferentes (baja, 7.95 × 104 unidades de cambio de color [CCU]/ave; media, 7.95 × 106 CCU/ave; y alta, 7.95 × 108 CCU/ave) a través de tres rutas diferentes (gota en el ojo, aerosol con gota fina e infección por contacto) se compararon y evaluaron utilizando diferentes parámetros. A los 14 días posteriores al desafío, no hubo mortalidades en ninguno de los grupos durante todo el estudio. Las pollitas de postura expuestas directamente a la dosis alta a través de la ruta de aerosol con gota fina mostraron los resultados más claros y consistentes (signos clínicos, PCR cuantitativa en tiempo real [qPCR] positiva, seroconversión, puntuación de lesiones en los sacos aéreos y cambios histopatológicos de la mucosa traqueal). Las dosis de desafío medias y bajas aplicadas mediante aerosol con gota fina o gota en el ojo no mostraron resultados consistentes. La cepa Rlow pudo propagarse a las aves infectadas por contacto, como lo confirmaron los resultados positivos de qPCR; sin embargo, ninguna de las aves infectadas por contacto mostró signos clínicos o lesiones macroscópicas o microscópicas. Estos resultados sugieren que una dosis alta (7.95 × 108 CCU/ave) administrada a través de una ruta de aerosol con gota fina es el modelo de elección en cualquier ensayo futuro de evaluación de vacunas para M. gallisepticum en pollitas de postura de 12 semanas de edad.


Subject(s)
Chickens , Mycoplasma Infections , Mycoplasma gallisepticum , Poultry Diseases , Animals , Poultry Diseases/microbiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/prevention & control , Bacterial Vaccines/administration & dosage , Bacterial Vaccines/immunology , Female
3.
Sci Rep ; 14(1): 12931, 2024 06 05.
Article in English | MEDLINE | ID: mdl-38839816

ABSTRACT

The present study aimed to investigate endothelial glycocalyx (eGCx) damage in cats with feline hemotropic mycoplasmosis caused by Mycoplasma haemofelis using selected biomarkers and to determine the diagnostic and prognostic significance of these biomarkers. The study included 25 cats with feline hemotropic mycoplasmosis and 10 healthy cats. Clinical examination, blood gas analysis, complete blood count, and biochemical analysis were performed. Hemotropic mycoplasmosis diagnosed by microscopic examination and molecularly confirmed by PCR targeting the Mycoplasma haemofelis 16s rRNA gene. To evaluate endothelial glycocalyx damage, syndecan-1, endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA), and vascular endothelial growth factor-A (VEGF-A) concentrations were measured using cat-specific commercial ELISA kits. Of the cats with feline hemotropic mycoplasmosis, 14 (56%) survived and 11 (44%) died. While syndecan-1 and ET-1 concentrations were significantly higher in cats with hemotropic mycoplasmosis compared to the control group (p < 0.001), no statistically significant difference was found for ADMA and VEGF-A concentrations (p > 0.05). Endothelial glycocalyx biomarkers showed significant correlations with each other and with hematological parameters (p < 0.01). The results of the ROC analysis showed that ET-1 with area under the curve (AUC) of 0.821 (p < 0.01) and VEGF-A with AUC of 0.805 (p < 0.010) were found to be significant prognostic indicators. In conclusion, this study demonstrated that serum syndecan-1 and ET-1 can be used as diagnostic and serum ET-1 and VEGF-A as prognostic biomarkers in cats with hemotropic mycoplasmosis. Our results indicate the development of eGCx damage in feline hemotropic mycoplasmosis and suggest that glycocalyx disruption may contribute to the pathogenesis of the disease.


Subject(s)
Biomarkers , Cat Diseases , Glycocalyx , Mycoplasma , Vascular Endothelial Growth Factor A , Animals , Cats , Glycocalyx/metabolism , Biomarkers/blood , Vascular Endothelial Growth Factor A/blood , Cat Diseases/microbiology , Cat Diseases/blood , Cat Diseases/diagnosis , Mycoplasma/genetics , Male , Female , Mycoplasma Infections/veterinary , Mycoplasma Infections/blood , Mycoplasma Infections/microbiology , Endothelin-1/blood , Syndecan-1/blood , Arginine/analogs & derivatives , Arginine/blood , Arginine/metabolism
4.
BMC Infect Dis ; 24(1): 562, 2024 Jun 05.
Article in English | MEDLINE | ID: mdl-38840040

ABSTRACT

BACKGROUND: The impact of chickens on maintaining the economy and livelihood of rural communities cannot be overemphasized. In recent years, mycoplasmosis has become one of the diseases that affect the success of South African chicken production. Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the most prevalent strains of Mycoplasma in South Africa. MG and MS are significant respiratory pathogens affecting the productivity of chickens. The present study aimed to molecularly detect using qPCR and characterize the presence of MG and MS using phylogenetic analysis. The phylogenetic analysis was utilized to clarify general evolutionary relationships between related taxa of different MG and MS observed in tracheal swabs from South African chicken breeds. METHODS: Forty-five tracheal swabs of the Lohmann Brown (n = 9), Rhode Island Red (n = 9), Ovambo (n = 9), Venda (n = 9), and Potchefstroom Koekoek (n = 9) breeds were collected from symptomatic chickens present in the commercial farm. To detect MG and MS, DNA was extracted from tracheal swabs and faecal samples, and qPCR was performed with a 16 s rRNA (310 bp) and vlhA (400 bp) gene fragment. Following the sequencing of all the amplicons, MG, and MS dendrograms showing the evolutionary relationships among the five South African chicken breeds and the GeneBank reference population were constructed. RESULTS: The qPCR revealed the presence of MG and MS in 22% (2/9) of the tracheal swab samples tested for MS only in Rhode Island Red breeds; 66.6% (6/9) and 33% (3/9) of the tested samples in Ovambo breeds; and 11.1% (1/9) and 44.4% (4/9) of the tested samples in Venda breeds. No MG or MS were detected in the Lohmann Brown or Potchefstroom Koekoek breed. Furthermore, qPCR revealed the presence of MG in pooled faecal samples from Lohmann Brown and Ovambo breeds. Eight different bacterial isolates were recognized from both samples. Four isolates were of the 16 s ribosomal ribonucleic acid (rRNA) gene (named PT/MG51/ck/00, PT/MG48/ck/00, PT/MG41/ck/00 and PT/MG71/ck/00) gene of Mycoplasma gallisepticum, and the other was Mycoplasma Synoviae variable lipoprotein hemagglutinin A (vlhA) gene (named PT/MSA22/ck/01, PT/MS41/ck/01, PT/MS74/ck/01 and PT/MS46/ck/01) which were available in GenBank. These isolates were successfully sequenced with 95-100% similarity to the isolates from the gene bank. CONCLUSION: The study revealed the presence of both MG and MS in the chicken breeds sampled. Furthermore, the different breeds of chicken were found to be susceptible to infection under the intensive or commercial management system. Therefore, continuous surveillance is encouraged to prevent the spread and outbreak of MG and MS in the poultry industry in South Africa.


Subject(s)
Chickens , Mycoplasma Infections , Mycoplasma gallisepticum , Mycoplasma synoviae , Phylogeny , Poultry Diseases , Animals , Chickens/microbiology , South Africa , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/epidemiology , Poultry Diseases/microbiology , Mycoplasma synoviae/genetics , Mycoplasma synoviae/isolation & purification , Mycoplasma synoviae/classification , Mycoplasma gallisepticum/genetics , Mycoplasma gallisepticum/isolation & purification , Mycoplasma gallisepticum/classification , Trachea/microbiology , RNA, Ribosomal, 16S/genetics , DNA, Bacterial/genetics , Feces/microbiology
5.
BMC Microbiol ; 24(1): 198, 2024 Jun 08.
Article in English | MEDLINE | ID: mdl-38849724

ABSTRACT

BACKGROUND: Hemotropic Mycoplasma species (hemoplasmas) cause hemolytic anemia in cats worldwide and are recognized as emerging zoonotic pathogens. There is no comprehensive study on the prevalence and species diversity of hemoplasmas in domestic cat populations in different regions in Iran. Thus, the aims of the present study were to provide data on the prevalence and molecular characterization of hemotropic Mycoplasma species in apparently healthy cats from six Iranian provinces with different climates. In addition, potential risk factors associated with hemoplasmosis in cats were assessed. RESULTS: Mycoplasma spp. DNA was detected in the blood of 56 / 361 cats (15.5%) using genus-specific PCR. Further examinations with species-specific PCR and Sanger sequencing showed that 38 cats (10.5%) tested positive for Candidatus Mycoplasma haemominutum (CMhm), 8 cats (2.2%) tested positive for Mycoplasma haemofelis (Mhf), and 2 cats (0.6%) tested positive for Candidatus Mycoplasma turicensis (CMt). Co-infection with CMhm, and Mhf was observed in 7 cats (1.9%). One cat (0.3%) showed mixed infection with CMhm, Mhf, and CMt. There were statistically significant relationships between Mycoplasma positivity and being female, living in shelter (cattery), and being over 3 years old (P < 0.05). No significant association was observed for the cat breed and sampling localities. CONCLUSIONS: Current study findings revealed that hemoplasma infections are common among Iran cat populations. Considering the impact of such emerging zoonotic pathogens on the One Health, routine screenings, increasing public awareness, effective control, and prophylactic strategies for minimizing infection in cats and subsequently in human are strongly recommended.


Subject(s)
Cat Diseases , DNA, Bacterial , Mycoplasma Infections , Mycoplasma , Phylogeny , Animals , Cats , Iran/epidemiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Cat Diseases/microbiology , Cat Diseases/epidemiology , Mycoplasma/genetics , Mycoplasma/isolation & purification , Mycoplasma/classification , Prevalence , Female , Male , DNA, Bacterial/genetics , Sequence Analysis, DNA , Polymerase Chain Reaction , Risk Factors , Coinfection/microbiology , Coinfection/veterinary , Coinfection/epidemiology
6.
J Vet Med Sci ; 86(7): 712-720, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38710622

ABSTRACT

Mycoplasma bovis mastitisis highly contagious and disrupts lactation, posing a significant threat to the dairy industry. While the mammary gland's defence mechanism involves epithelial cells and mononuclear cells (MNC), their interaction with M. bovis remains incompletely understood. In this study, we assessed the immunological reactivity of bovine mammary epithelial cells (bMEC) to M. bovis through co-culture with MNC. Upon co-culture with MNC, the mRNA expression levels of interleukin (IL)-1ß, IL-6, IL-8 and tumor necrosis factor (TNF)-α in bMEC stimulated by M. bovis showed a significant increase compared to monoculture. Additionally, when stimulated with M. bovis, the culture supernatant exhibited significantly higher concentrations of IL-6 and interferon (IFN)-γ, while IL-1ß concentration tended to be higher in co-culture with MNC than in monoculture. Furthermore, the mRNA expression levels of toll-like receptor (TLR) 2 in bMEC stimulated with M. bovis tended to increase, and TLR4 significantly increased when co-cultured with MNC compared to monocultures. However, the surface expression levels in bMEC did not exhibit significant changes between co-culture and monoculture. Overall, our research indicates that the inflammatory response of bMEC is increased during co-culture with MNC, suggesting that the interaction between bMEC and MNC in the mammary gland amplifies the immune response to M. bovis in cows affected by M. bovis mastitis.


Subject(s)
Coculture Techniques , Epithelial Cells , Immunity, Innate , Mammary Glands, Animal , Mastitis, Bovine , Mycoplasma Infections , Mycoplasma bovis , Animals , Cattle , Mycoplasma bovis/immunology , Mastitis, Bovine/immunology , Mastitis, Bovine/microbiology , Female , Epithelial Cells/immunology , Epithelial Cells/microbiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/immunology , Mycoplasma Infections/microbiology , Coculture Techniques/veterinary , Mammary Glands, Animal/immunology , Mammary Glands, Animal/microbiology , Cytokines/metabolism , Cytokines/genetics , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/microbiology , Cells, Cultured
7.
J Wildl Dis ; 60(3): 594-604, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38757149

ABSTRACT

Mycoplasma bovis (M. bovis) is an important pathogen of American bison (Bison bison), associated with high morbidity and mortality epizootics of respiratory and reproductive disease. Despite the significant negative impact on bison health, little is known about the kinetics of disease and the host immune response to infection. To address these questions, a cohort of bison calves was created and serially sampled 5 times, once every 2-3 mo, over a 12-mo period. At each sampling period nasal swab samples were collected and tested by PCR for the presence of M. bovis. Serum samples were also collected and assessed for M. bovis-specific antibodies using both a commercial and an in-house ELISA. Overall, 19/41 bison (46.3%) had positive PCR tests, and 31/41 (75.6%) were seropositive. Over the course of the study, the frequency of PCR-positive nasal swabs and the ELISA scores decreased, although serum samples remained positive for at least 6 mo following the final positive PCR test. Bison were grouped according to results from the in-house ELISA into high-responder (n=7), low-responder (n=5), and seronegative (n=7) groups. M. bovis-specific IgG antibody levels were significantly elevated in the high-responder group compared to the low-responder and seronegative groups. The differences were statistically significant for 3/5 sampling periods. A trend toward increased IgG2 levels was observed in the high-responder group. High total IgG responses correlated with a decline in positive PCR tests from nasal swabs. These data provide evidence that a strong humoral response is beneficial and is probably involved in the clearance of M. bovis from bison.


Subject(s)
Antibodies, Bacterial , Bison , Immunoglobulin G , Mycoplasma Infections , Mycoplasma bovis , Polymerase Chain Reaction , Animals , Bison/microbiology , Mycoplasma bovis/immunology , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Immunoglobulin G/blood , Polymerase Chain Reaction/veterinary , Antibodies, Bacterial/blood , Male , Female , Enzyme-Linked Immunosorbent Assay/veterinary
8.
J Wildl Dis ; 60(3): 584-593, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38768955

ABSTRACT

Mycoplasma bovis is a bacterial pathogen endemic to cattle. In the early 2000s, M. bovis emerged as a cause of respiratory disease in American bison (Bison bison), causing significant morbidity and mortality. Bison herds that experience an outbreak of M. bovis are at higher risk for subsequent outbreaks, suggesting that chronic, subclinical infections can be established. Antemortem testing is therefore crucial to disease management; however, the precise sampling method to maximize detection of M. bovis in bison is unknown. We evaluated two sample types-superficial nasal swabs and deep nasopharyngeal swabs-collected from apparently healthy or symptomatic bison from January 2021 through December 2022. We used real-time PCR to detect M. bovis in 76/938 bison (8.1%) from 11 herds. For bison testing positive on at least one swab type, M. bovis was detected in 63/76 (82.8%) deep nasopharyngeal swabs and 29/73 (38.1%) superficial nasal swabs. Agreement between swabs for positive bison was 21% (n=16, kappa coefficient 0.319). We conclude that deep nasopharyngeal swabbing is more sensitive than superficial nasal swabbing for detection of M. bovis in bison and that low agreement between methods may be related to stage of infection. We further tested pooled samples by PCR and found that pooling of up to five samples can be effective to increase throughput and minimize costs. Management of wild bison relies on the ability to relocate animals to maintain gene flow and healthy populations. Sensitive and specific diagnostic tests are needed to inform decisions and minimize risk of transmission, especially from subclinical carriers. This study provides valuable insight that will inform best practices for M. bovis testing, thereby supporting the conservation of bison as healthy wildlife, which in turn promotes ecological restoration, safeguards cultural practices of Tribal Nations, and upholds the bison as a unique American icon.


Subject(s)
Bison , Mycoplasma Infections , Mycoplasma bovis , Animals , Bison/microbiology , Mycoplasma bovis/isolation & purification , Mycoplasma bovis/genetics , Mycoplasma Infections/veterinary , Mycoplasma Infections/diagnosis , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Specimen Handling/veterinary , Nasopharynx/microbiology , Female
9.
Vet Microbiol ; 294: 110119, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38772075

ABSTRACT

Mycoplasma synoviae causes infectious synovitis and respiratory tract infections in chickens and is responsible for significant economic losses in the poultry industry. Effective attachment and colonisation of the trachea is critical for the persistence of the organism and progression of the disease it causes. The respiratory tract infection is usually sub-clinical, but concurrent infection with infectious bronchitis virus (IBV) is known to enhance the pathogenicity of M. synoviae. This study aimed to explore differentially expressed genes in the tracheal mucosa, and their functional categories, during chronic infection with M. synoviae, using a M. synoviae-IBV infection model. The transcriptional profiles of the trachea were assessed 2 weeks after infection using RNA sequencing. In chickens infected with M. synoviae or IBV, only 1 or 8 genes were differentially expressed compared to uninfected chickens, respectively. In contrast, the M. synoviae-IBV infected chickens had 621 upregulated and 206 downregulated genes compared to uninfected chickens. Upregulated genes and their functional categories were suggestive of uncontrolled lymphoid cell proliferation and an ongoing pro-inflammatory response. Genes associated with anti-inflammatory effects, pathogen removal, apoptosis, regulation of the immune response, airway homoeostasis, cell adhesion and tissue regeneration were downregulated. Overall, transcriptional changes in the trachea, 2 weeks after infection with M. synoviae and IBV, indicate immune dysregulation, robust inflammation and a lack of cytotoxic damage during chronic infection. This model provides insights into the pathogenesis of chronic infection with M. synoviae.


Subject(s)
Chickens , Mycoplasma Infections , Mycoplasma synoviae , Poultry Diseases , Trachea , Animals , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/immunology , Poultry Diseases/microbiology , Poultry Diseases/virology , Poultry Diseases/immunology , Mycoplasma synoviae/genetics , Trachea/microbiology , Trachea/virology , Infectious bronchitis virus/genetics , Infectious bronchitis virus/immunology , Infectious bronchitis virus/physiology , Chronic Disease , Coronavirus Infections/veterinary , Coronavirus Infections/virology , Coronavirus Infections/immunology , Transcriptome , Gene Expression Profiling , Coinfection/veterinary , Coinfection/microbiology , Coinfection/virology
10.
Comp Immunol Microbiol Infect Dis ; 109: 102187, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38703540

ABSTRACT

Hemotropic mycoplasmas are bacteria that attaches to erythrocytes surface, which some species presents zoonotic concerns. In the suborder Pinnipedia, genera Otaria and Arctocephalus are prominent in Brazil. This study investigated the occurrence of hemoplasmas in Arctocephalus sp. and Otaria flavescens found dead along the coast of a Southern Brazilian State. DNA from 135 spleen samples were extracted and subjected to conventional PCR protocols, targeting the 16 S rRNA and 23 S rRNA gene. Three (2.22 %) Arctocephalus australis were positive in the 16 S rRNA gene, and no samples amplified in the 23 S rRNA gene. Samples from this study clustered with Zalophus californianus and Arctocephalus tropicalis mycoplasmas on a Bayesian phylogenetic analysis. Genetic diversity analysis suggested distinct genotypes, indicating A. australis as a new host for hemoplasma, and also a potential putative novel hemoplasma genotype. These findings raises future awareness for pinnipeds conservation, and adds Mycoplasma spp. to be taken into consideration when clinically evaluating rescued animals.


Subject(s)
DNA, Bacterial , Fur Seals , Mycoplasma Infections , Mycoplasma , Phylogeny , RNA, Ribosomal, 16S , Spleen , Animals , Brazil/epidemiology , Mycoplasma/genetics , Mycoplasma/isolation & purification , Mycoplasma/classification , Fur Seals/microbiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/epidemiology , RNA, Ribosomal, 16S/genetics , DNA, Bacterial/genetics , Spleen/microbiology , RNA, Ribosomal, 23S/genetics , Genetic Variation , Genotype , Bayes Theorem , Autopsy/veterinary , Polymerase Chain Reaction
11.
Parasit Vectors ; 17(1): 209, 2024 May 09.
Article in English | MEDLINE | ID: mdl-38720359

ABSTRACT

BACKGROUND: Feline-associated hemotropic Mycoplasma (hemoplasmas) are believed to be transmitted by two primary mechanisms: (1) direct transmission via fighting and (2) vector-borne transmission by the cat flea (Ctenocephalides felis). While the efficiency of transmission by C. felis appears low, most manuscripts focus on the prevalence of hemoplasmas in wild-caught fleas and report either a very low (< 3%) or a high (> 26%) prevalence. Therefore, we aimed to assess the influence of sample processing and PCR methods on C. felis hemoplasma infection prevalence. METHODS: A systemic review of PubMed articles identified 13 manuscripts (1,531 fleas/flea pools) that met the inclusion criteria (performed PCR for >1 hemoplasma on C. felis collected from cats). Risk of bias was assessed utilizing the ROBINS-E tool. Meta-analysis performed in R of these manuscripts found that not washing samples and a common set of 16S rRNA primers first published in Jensen et al. 2001 were associated with increased hemoplasma prevalence. To evaluate the influence of washing on newly collected fleas, we assessed the hemoplasma status of 20 pools of 5 C. felis each, half of which were washed and half not washed. RESULTS: Flea washing did not influence the detection of hemoplasma but instead amplified Spiroplasma. To assess non-specific amplification with the Jensen et al. 2001 primers, 67 C. felis samples (34% previously reported hemoplasma infected) were subject to PCR and sequencing. By this method, hemoplasma was detected in only 3% of samples. In the remaining "hemoplasma infected" fleas, PCR amplified Spiroplasma or other bacteria. CONCLUSIONS: Therefore, we concluded that hemoplasma infection in C. felis is rare, and future flea prevalence studies should sequence all positive amplicons to validate PCR specificity. Further investigation of alternative methods of feline-associated hemoplasma transmission and the ability of C. felis to maintain hemoplasma infection is necessary.


Subject(s)
Cat Diseases , Ctenocephalides , Mycoplasma Infections , Mycoplasma , Animals , Mycoplasma/isolation & purification , Mycoplasma/genetics , Mycoplasma/classification , Ctenocephalides/microbiology , Cats , Cat Diseases/parasitology , Cat Diseases/microbiology , Cat Diseases/diagnosis , Cat Diseases/transmission , Cat Diseases/epidemiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/diagnosis , Mycoplasma Infections/epidemiology , Mycoplasma Infections/transmission , Mycoplasma Infections/microbiology , Flea Infestations/veterinary , Flea Infestations/parasitology , Flea Infestations/epidemiology , Polymerase Chain Reaction , Prevalence , RNA, Ribosomal, 16S/genetics
12.
Vet Q ; 44(1): 1-11, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38711265

ABSTRACT

Our study aimed to evaluate the effect of different treatments for BRD on health and welfare in fattening bulls. A total of 264 bulls were enrolled. Welfare was assessed on day 2 (T0) and day 15 (T1) after arrival. A decrease in the welfare level was observed from T0 to T1. All bulls were inspected clinically at T0 and T1 revealing an increase of skin lesions and lameness in T1. In both periods, a high incidence of respiratory disease was observed. A prevalence of 79.55% and 95.45% of Mycoplasma bovis using RT-PCR and culture at T0 and T1 respectively was observed. Blood samples were collected for haematology at T0 and T1. At T0, 36 animals were individually treated for BRD with an antimicrobial (IT), 54 received a metaphylactic treatment with tulathromycin (M), 150 received a metaphylactic treatment with tulathromycin plus a second antimicrobial (M + IT) whereas 24 were considered healthy and therefore not treated (NT). Additionally, 128 were treated with a non-steroid anti-inflammatory (NSAID). Neutrophils of M + IT were significantly higher than groups NT and M and the lymphocytes of M + IT were significantly lower than that of IT. White blood cells, neutrophils and N/L ratio of animals treated with an NSAID was significantly higher than that not treated. Lung inspection of 172 bulls at the abattoir indicated that 92.43% presented at least one lung lesion. A statistically significant effect of the NSAID treatment on the lung lesions was observed. Our findings indicate that BRD was a major welfare and health concern and evidence the difficulties of antimicrobial treatment of M. bovis.


Subject(s)
Animal Welfare , Anti-Inflammatory Agents, Non-Steroidal , Heterocyclic Compounds , Macrolides , Animals , Cattle , Male , Cross-Sectional Studies , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Disaccharides/pharmacology , Disaccharides/therapeutic use , Cattle Diseases/drug therapy , Cattle Diseases/microbiology , Mycoplasma bovis/drug effects , Anti-Infective Agents/therapeutic use , Anti-Infective Agents/pharmacology , Mycoplasma Infections/veterinary , Mycoplasma Infections/drug therapy
13.
Ticks Tick Borne Dis ; 15(5): 102351, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38788485

ABSTRACT

The transplacental transmission of parasites and hemoparasites is crucial for understanding the epidemiology of diseases. This study aimed to assess the prevalence of hemopathogens in bovine fetuses at various gestational periods. Samples were obtained from a slaughterhouse in the state of Minas Gerais, Brazil, and a total of 236 fetuses were collected. DNA extracted from blood samples (145) and organ samples (a pool of brain and spleen) (236) underwent a nested PCR (nPCR) assay to detect Babesia spp., Theileria spp., Trypanosoma vivax, Anaplasma marginale, Anaplasma bovis, Anaplasma phagocytophilum, Ehrlichia minasensis, and hemotropic Mycoplasma spp. Additionally, serological analysis of 145 plasma samples was conducted using the indirect fluorescent antibody test-IFAT to detect IgG against Babesia bovis, Babesia bigemina, A. marginale, and Trypanosoma vivax. The observed prevalence of transplacental transmission was 19.3 %, 6.2 %, 42.7 % and 2.7 %, for A. marginale, B. bigemina, 'Candidatus M. haemobos', and Mycoplasma wenyonii, respectively. The prevalence of A. marginale by gestational trimester was 16 % (13/81) in the second trimester and 23 % (14/60) in the third trimester, with no positive samples in the first trimester. Regarding the species B. bovis and B. bigemina, all evaluated animals tested negative by nPCR, and no serological evidence for B. bovis was found by the IFAT. Babesia bigemina demonstrated an overall seroprevalence of 6.2 % (9/145), with 4.8 % (7/145) in the last trimester and 1.3 % (2/145) in the second trimester of pregnancy. In total, 42.7 % (62/145) of blood samples were positive for 'Candidatus M. haemobos', with 42 % (34/81) in the middle trimester, and 43 % (26/60) in the final trimester of pregnancy. Mycoplasma wenyonni was detected in 2.7 % (4/145) blood samples, all in coinfection with 'C. M. haemobos'. The prevalence by pregnancy trimester was 25 % (1/4) in the first trimester; 1.2 % (1/81) in the second trimester and 3.3 % (2/60) in the third trimester of pregnancy. Hemopathogen DNA was detected in fetus blood samples but not the brain or spleen samples. All the samples were negative for T. vivax, Theileria spp., Anaplasma spp. and Ehrlichia spp. Overall, in this study, approximately 70 % of fetuses were positive for one or more of the studied parasites. No significant associations were observed between pairs of pathogens, except 'C. M. haemobos' and A. marginale.


Subject(s)
Cattle Diseases , Mycoplasma , Animals , Brazil/epidemiology , Cattle , Female , Cattle Diseases/epidemiology , Cattle Diseases/microbiology , Cattle Diseases/parasitology , Mycoplasma/isolation & purification , Pregnancy , Prevalence , Babesia/isolation & purification , Fetus/microbiology , Fetus/parasitology , Mycoplasma Infections/epidemiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Theileria/isolation & purification , Trypanosoma vivax/isolation & purification , Infectious Disease Transmission, Vertical/veterinary , Anaplasma/isolation & purification , Babesiosis/epidemiology , Babesiosis/parasitology , Anaplasmosis/epidemiology , Anaplasmosis/microbiology , Ehrlichia/isolation & purification
14.
Vet Immunol Immunopathol ; 272: 110768, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38703559

ABSTRACT

The Mycoplasma hyorhinis (Mhr) variable lipoprotein (Vlp) family, comprising Vlps A, B, C, D, E, F, and G, are highly variable in expression, size, and cytoadhesion capabilities across Mhr strains. The 'Vlp system' plays a crucial role in cytoadhesion, immune evasion, and in eliciting a host immunologic response. This pilot study described the development of Vlp peptide-based ELISAs to evaluate the antigenic reactivity of individual Vlps against Mhr antisera collected throughout a longitudinal study focused on Mhr strain 38983, reproducing Mhr-associated disease under experimental conditions. Specifically, serum samples were collected at day post-inoculation 0, 7, 10, 14, 17, 21, 24, 28, 35, 42, 49, and 56 from Mhr- and mock (Friis medium)-inoculated cesarean-derived, colostrum-deprived pigs. Significant Mhr-specific IgG responses were detected at specific time points throughout the infection, with some variations for each Vlp. Overall, individual Vlp ELISAs showed consistently high accuracy rates, except for VlpD, which would likely be associated with its expression levels or the anti-Vlp humoral immune response specific to the Mhr strain used in this study. This study provides the basis and tools for a more refined understanding of these Vlp- and Mhr strain-specific variations, which is foundational in understanding the host immune response to Mhr.


Subject(s)
Lipoproteins , Mycoplasma Infections , Mycoplasma hyorhinis , Animals , Lipoproteins/immunology , Mycoplasma hyorhinis/immunology , Mycoplasma Infections/immunology , Mycoplasma Infections/veterinary , Swine/immunology , Enzyme-Linked Immunosorbent Assay/veterinary , Pilot Projects , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Antigens, Bacterial/immunology , Swine Diseases/immunology , Swine Diseases/microbiology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Female , Bacterial Proteins/immunology , Longitudinal Studies
15.
Vet Microbiol ; 293: 110093, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38692193

ABSTRACT

Mycoplasma gallisepticum causes chronic respiratory disease in poultry. A novel vaccine, Vaxsafe MG304 (the ts-304 strain), has greater protective efficacy in chickens than the Vaxsafe MG (strain ts-11) vaccine when delivered by eye drop at 3 weeks of age. Applying this vaccine in the hatchery to 1-day-old birds, using mass administration methods, would improve animal welfare and reduce labour costs associated with handling individual birds. This study assessed the protection provided by vaccination with Vaxsafe MG304 after administration to 1-day-old chicks. Chicks were administered a single dose of the vaccine to assess the efficacy of either a high dose (107.0 colour changing units, CCU) or a low dose (105.7 CCU) after eye drop or spray (in water or gel) administration against experimental challenge with virulent M. gallisepticum strain Ap3AS at 7 weeks of age. The vaccine was able to colonise the palatine cleft of chicks after vaccination by eye drop (at both doses) or by spray (in water or gel) (at the high dose). The high dose of vaccine, when delivered by eye drop or spray, was shown to be safe and induced a serological response and protective immunity (as measured by tracheal mucosal thickness and air sac lesion scores) against challenge. Vaccination of 1-day-old chicks with Vaxsafe MG304 by eye drop induced protective immunity equivalent to vaccination at 3 weeks of age. Vaxsafe MG304 was also protective when applied by both coarse- and gel spray methods at the higher dose and is therefore a suitable live attenuated vaccine for use in 1-day-old chicks.


Subject(s)
Antibodies, Bacterial , Bacterial Vaccines , Chickens , Mycoplasma Infections , Mycoplasma gallisepticum , Poultry Diseases , Vaccination , Animals , Mycoplasma gallisepticum/immunology , Chickens/immunology , Chickens/microbiology , Poultry Diseases/prevention & control , Poultry Diseases/microbiology , Bacterial Vaccines/immunology , Bacterial Vaccines/administration & dosage , Mycoplasma Infections/prevention & control , Mycoplasma Infections/veterinary , Mycoplasma Infections/immunology , Specific Pathogen-Free Organisms , Vaccination/veterinary , Antibodies, Bacterial/blood
16.
Poult Sci ; 103(7): 103690, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38663076

ABSTRACT

Routine antibiotic administration has been used in intensive animal industries for a long time for health and production benefits. There is now a concerted effort to limit antibiotics administration to only treatment of clinically affected animals and to look for other alternative solutions combined with better husbandry practices for the benefits routine antibiotic administration seems to provide in intensive farming systems. In this paper it is argued that the benefits from routine antibiotics in chickens administration in lay are from suppression of the effects of mycoplasma infections. Mycoplasma freedom has been recommended but is not always practical. Vaccination of mycoplasma negative chickens with live mycoplasma vaccines is now being used (with biosecurity) to decrease antibiotic dependence in lay of poultry in many parts of the world.


Subject(s)
Animal Husbandry , Anti-Bacterial Agents , Chickens , Drug Resistance, Bacterial , Mycoplasma Infections , Poultry Diseases , Animals , Animal Husbandry/methods , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/administration & dosage , Bacterial Vaccines , Mycoplasma/drug effects , Mycoplasma Infections/veterinary , Mycoplasma Infections/drug therapy , Mycoplasma Infections/prevention & control , One Health , Poultry Diseases/microbiology , Poultry Diseases/prevention & control
17.
Microbiol Res ; 284: 127727, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38636241

ABSTRACT

Heme oxygenase HO-1 (HMOX) regulates cellular inflammation and apoptosis, but its role in regulation of autophagy in Mycoplasma bovis infection is unknown. The objective was to determine how the HO-1/CO- Protein kinase RNA-like endoplasmic reticulum kinase (PERK)-Ca2+- transcription factor EB (TFEB) signaling axis induces autophagy and regulates clearance of M. bovis by bovine mammary epithelial cells (bMECs). M. bovis inhibited autophagy and lysosomal biogenesis in bMECs and suppressed HO-1 protein and expression of related proteins, namely nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (keap1). Activation of HO-1 and its production of carbon monoxide (CO) were required for induction of autophagy and clearance of intracellular M. bovis. Furthermore, when HO-1 was deficient, CO sustained cellular autophagy. HO-1 activation increased intracellular calcium (Ca2+) and cytosolic localization activity of TFEB via PERK. Knockdown of PERK or chelation of intracellular Ca2+ inhibited HO-1-induced M. bovis autophagy and clearance. M. bovis infection affected nuclear localization of lysosomal TFEB in the MiT/TFE transcription factor subfamily, whereas activation of HO-1 mediated dephosphorylation and intranuclear localization of TFEB, promoting autophagy, lysosomal biogenesis and autophagic clearance of M. bovis. Nuclear translocation of TFEB in HO-1 was critical to induce M. bovis transport and survival of infected bMECs. Furthermore, the HO-1/CO-PERK-Ca2+-TFEB signaling axis induced autophagy and M. bovis clearance, providing a viable approach to treat persistent M. bovis infections.


Subject(s)
Autophagy , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Calcium , Cell Nucleus , Endoplasmic Reticulum , Epithelial Cells , Mammary Glands, Animal , Mycoplasma bovis , Animals , Cattle , Epithelial Cells/microbiology , Epithelial Cells/metabolism , Calcium/metabolism , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Endoplasmic Reticulum/metabolism , Mammary Glands, Animal/microbiology , Mammary Glands, Animal/metabolism , Cell Nucleus/metabolism , Female , eIF-2 Kinase/metabolism , eIF-2 Kinase/genetics , Mycoplasma Infections/microbiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/metabolism , Lysosomes/metabolism , Heme Oxygenase-1/metabolism , Heme Oxygenase-1/genetics , Carbon Monoxide/metabolism , Signal Transduction , NF-E2-Related Factor 2/metabolism , NF-E2-Related Factor 2/genetics
18.
Acta Trop ; 254: 107215, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38604328

ABSTRACT

The livestock sector of Pakistan is increasing rapidly and it plays important role both for rural community and national economy. It is estimated that almost 8 million rural people are involved in livestock rearing and earning about 35-40 % of their income from the livestock sector. Mycoplasma bovis (M. bovis) infection causes significant economic losses in dairy animals especially young calf in the form of clinical illnesses such as pneumonia, poly-arthritis, respiratory distress and mortality. M. bovis is hard to diagnose and control because of uneven disease appearance and it is usually noticed in asymptomatic animals. For the identification of M. bovis in sub-clinical and clinical samples, determination of acute phase proteins i.e., haptoglobin (Hp) and serum amyloid A (SAA) are important tools for the timely diagnosis of disease. Therefore, early diagnosis of disease and hemato-biochemical changes are considered beneficial tools to control the infectious agent to uplift the economy of the dairy farmers. For this purpose, blood samples were collected from 200 calves of Bovidae family. Serum was separated from blood samples to determine the concentration of Hp and SAA, while blood samples were processed to determine hematological changes in blood from calves by using hematological analyzer. The blood plasma obtained from the blood samples was processed to measure oxidative stress factors. Lungs tissues from slaughterhouses/ morbid calves were collected to observe histopathological changes. The results of present study indicated that level of SAA and Hp remarkably increased (P < 0.05) in M. bovis infected calves in comparison to healthy calves. The oxidative stress markers indicated that nitric oxide and MDA levels in the infected calves increased significantly (P < 0.05), while infected claves had considerably lower levels of superoxide dismutase, catalase and glutathione. These findings indicate that oxidative stress play role to increase the level of APPs, while monitoring of APPs levels may serve as a valuable addition to the clinical evaluation of naturally infected calves with M. bovis. The hematological parameters were decreased significantly (P < 0.05). Altogether, this study suggests that Hp and SAA are proposed as promising biomarkers for detecting naturally occurring M. bovis infection in calves.


Subject(s)
Biomarkers , Cattle Diseases , Haptoglobins , Mycoplasma Infections , Mycoplasma bovis , Serum Amyloid A Protein , Animals , Haptoglobins/analysis , Haptoglobins/metabolism , Cattle , Serum Amyloid A Protein/analysis , Mycoplasma Infections/veterinary , Mycoplasma Infections/diagnosis , Mycoplasma Infections/blood , Mycoplasma Infections/microbiology , Cattle Diseases/diagnosis , Cattle Diseases/microbiology , Cattle Diseases/blood , Biomarkers/blood , Pakistan , Lung/pathology , Lung/microbiology , Oxidative Stress
19.
Front Immunol ; 15: 1367253, 2024.
Article in English | MEDLINE | ID: mdl-38646533

ABSTRACT

Bovine respiratory disease (BRD) is one of the most common diseases in the cattle industry worldwide; it is caused by multiple bacterial or viral coinfections, of which Mycoplasma bovis (M. bovis) and bovine herpesvirus type 1 (BoHV-1) are the most notable pathogens. Although live vaccines have demonstrated better efficacy against BRD induced by both pathogens, there are no combined live and marker vaccines. Therefore, we developed an attenuated and marker M. bovis-BoHV-1 combined vaccine based on the M. bovis HB150 and BoHV-1 gG-/tk- strain previously constructed in our lab and evaluated in rabbits. This study aimed to further evaluate its safety and protective efficacy in cattle using different antigen ratios. After immunization, all vaccinated cattle had a normal rectal temperature and mental status without respiratory symptoms. CD4+, CD8+, and CD19+ cells significantly increased in immunized cattle and induced higher humoral and cellular immune responses, and the expression of key cytokines such as IL-4, IL-12, TNF-α, and IFN-γ can be promoted after vaccination. The 1.0 × 108 CFU of M. bovis HB150 and 1.0 × 106 TCID50 BoHV-1 gG-/tk- combined strain elicited the most antibodies while significantly increasing IgG and cellular immunity after challenge. In conclusion, the M. bovis HB150 and BoHV-1 gG-/tk- combined strain was clinically safe and protective in calves; the mix of 1.0 × 108 CFU of M. bovis HB150 and 1.0 × 106 TCID50 BoHV-1 gG-/tk- strain was most promising due to its low amount of shedding and highest humoral and cellular immune responses compared with others. This study introduces an M. bovis-BoHV-1 combined vaccine for application in the cattle industry.


Subject(s)
Herpesvirus 1, Bovine , Mycoplasma bovis , Vaccines, Attenuated , Vaccines, Combined , Animals , Cattle , Herpesvirus 1, Bovine/immunology , Vaccines, Combined/immunology , Vaccines, Combined/administration & dosage , Vaccines, Attenuated/immunology , Vaccines, Attenuated/administration & dosage , Mycoplasma bovis/immunology , Viral Vaccines/immunology , Viral Vaccines/administration & dosage , Viral Vaccines/adverse effects , Bacterial Vaccines/immunology , Bacterial Vaccines/administration & dosage , Bacterial Vaccines/adverse effects , Cytokines/metabolism , Antibodies, Viral/blood , Antibodies, Viral/immunology , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Mycoplasma Infections/prevention & control , Mycoplasma Infections/veterinary , Mycoplasma Infections/immunology , Vaccines, Marker/immunology , Vaccines, Marker/administration & dosage , Vaccination/veterinary , Vaccine Efficacy , Immunity, Humoral , Bovine Respiratory Disease Complex/prevention & control , Bovine Respiratory Disease Complex/immunology , Bovine Respiratory Disease Complex/virology
20.
J Wildl Dis ; 60(3): 783-785, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38533628

ABSTRACT

Lower respiratory tract disease associated with mycoplasmal infection was detected in a free-ranging bog turtle (Glyptemys muhlenbergii) from New Jersey, USA. The presence of a mycoplasmal organism was confirmed by PCR and electron microscopy. Fluid-filled lungs were observed grossly, and there was proliferative pneumonia on histopathology.


Subject(s)
Turtles , Animals , Turtles/microbiology , Mycoplasma Infections/veterinary , Mycoplasma Infections/microbiology , Mycoplasma Infections/pathology , Female , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...